HealthTech

Regard

Regard raises $61M Series B at $320M valuation

$61M
Total Raised
Series B
Latest Round
2021
Founded
100+
Employees
Los Angeles, CA
1 min read

Quick Facts

Valuation
$320M
Latest Round Size
$61M
Latest Round Date
September 2024

Regard: Series B Funding Round

Regard has successfully raised $61M in Series B funding, reaching a valuation of $320M.

Company Overview

AI clinical insights platform for physicians and care teams

Funding Details

The Series B round was led by Oak HC/FT, with participation from TCV.

Company Information

  • Headquarters: Los Angeles, CA
  • Founded: 2021
  • Employees: 100+
  • Category: HealthTech

Investment

Regard plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

  • Oak HC/FT: Verified investor in Series B
  • TCV: Verified investor in Series B

Key Investors

Oak HC/FT
Lead Investor
Verified investor in Series B
TCV
Investor
Verified investor in Series B

About the Author

Editorial Team
Editorial Team
Curated funding news from verified sources